Glaucoma surgery methods and systems

• US 9,642,746 B2
• Filed: 02/26/2014
• Issued: 05/09/2017
• Est. Priority Date: 05/21/2001
• Status: Expired due to Term

• Current Assignee: Berlin Michael
• Original Assignee: Berlin Michael
• Inventors: Berlin, Michael
• Primary Examiner(s): Bosworth, Kami A
• Application Number:
  US14/191,277
• Publication Number:
  US 20140288485A1
• Time in Patent Office: 1,168 Days
• CPC Class Codes: A61F 2009/00844 Feedback systems
• CPC Class Codes: A61F 2009/00868 Ciliary muscles or trabecular meshwork
• CPC Class Codes: A61F 2009/00891 Glaucoma
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002
• CPC Class Codes: A61F 9/00802 for photoablation

Abstract

Methods and systems are disclosed for creating an aqueous flow pathway in the trabecular meshwork, juxtacanalicular trabecular meshwork and Schlemm'"'"'s canal of an eye for reducing elevated intraocular pressure. Some embodiments described apparatus and methods useful in photoablation of tissues. In some embodiments, a photoablation apparatus is used to perforate a tissue, forming an aperture into a space behind the tissue. Gases formed during a photoablation process can be used to pressurize the space behind the tissue to enhance patency of the space. In some embodiments the tissue is the trabecular meshwork of the eye and a wall of Schlemm'"'"'s canal, and the space behind the tissue is a portion of the lumen of Schlemm'"'"'s canal. In some embodiments, the method is useful in the treatment of glaucoma by improving outflow from the anterior chamber of the eye into Schlemm'"'"'s canal, reducing intraocular pressure.

Claims

1. A method, for treating glaucoma in an eye, the eye comprising an anterior chamber, a Schlemm'"'"'s canal and a trabecular meshwork therebetween, the method comprising:

photoablating ocular tissue at a first treatment site, resulting in the formation of a first aperture in the ocular tissue, the first aperture extending from the anterior chamber through the trabecular meshwork into the Schlemm'"'"'s canal; and

photoablating the ocular tissue at a second treatment site, resulting in the formation of a second aperture in the ocular tissue, the second aperture extending from the anterior chamber through the trabecular meshwork into the Schlemm'"'"'s canal;

wherein photoablating the ocular tissue at the second treatment site generates a pressurized gas that travels along the Schlemm'"'"'s canal toward the first aperture.

2. The method of claim 1, wherein the Schlemm'"'"'s canal is dilated with the pressurized gas between the first aperture and the second aperture.

3. The method of claim 1, wherein the pressurized gas from the second treatment site travels along the Schlemm'"'"'s canal to the first aperture.

4. The method of claim 1, wherein the photoablating of the ocular tissue at the second treatment site is performed in an enclosed volume of the eye and the pressurized gas provides an increase in pressure within the enclosed volume.

5. The method of claim 1, wherein the Schlemm'"'"'s canal is dilated with the pressurized gas and dilation of the Schlemm'"'"'s canal allows a larger volume of flow through the Schlemm'"'"'s canal, thereby increasing outflow.

6. The method of claim 1, wherein treatment comprises the photoablating ocular tissue at the first treatment site and the photoablating ocular tissue at the second treatment site and wherein an intraocular pressure of the eye is decreased by 20% or more after the treatment as compared to before the treatment.

7. The method of claim 1, wherein the pressurized gas provides dilation of confluent connector channels in the eye.

8. The method of claim 1, comprising:

controlling the pressurized gas generation, by controlling at least one of;

(1) process parameters applied during the photoablating of the ocular tissue at each of the first and second treatment sites, (2) an environment surrounding each of the first and second treatment sites, or (3) a size of a photoablation probe that is used for the photoablating of the ocular tissue at the each of the first and second treatment sites.

9. The method of claim 8, wherein the pressurized gas generation forms a gas bubble and wherein the controlling of the pressurized gas generation comprises controlling at least one of:

(1) a size of the gas bubble, (2) a rate of gas bubble formation, (3) expansion of the gas bubble, or (4) directionality of movement of the gas bubble within and along the Schlemm'"'"'s canal.

10. The method of claim 8, wherein the process parameters comprise a pulse duration, repetition rate, and/or photon density of a laser that is used for the photoablating of the ocular tissue at each of the first and second treatment sites.

11. The method of claim 1, wherein a number of apertures formed in the ocular tissue between the anterior chamber and the Schlemm'"'"'s canal is more than two, the number of apertures including the first aperture and the second aperture.

12. A method, for treating glaucoma in an eye, the eye comprising an anterior chamber, a Schlemm'"'"'s canal and a trabecular meshwork therebetween, the method comprising:

photoablating ocular tissue at a first treatment site, resulting in the formation of a first aperture in the ocular tissue, the first aperture extending from the anterior chamber through the trabecular meshwork into the Schlemm'"'"'s canal; and

photoablating the ocular tissue at a second treatment site, resulting in the formation of a second aperture in the ocular tissue, the second aperture extending from the anterior chamber through the trabecular meshwork into the Schlemm'"'"'s canal;

wherein photoablating the ocular tissue at the second treatment site generates a gas bubble that travels along the Schlemm'"'"'s canal toward the first aperture.

13. The method of claim 12, wherein the gas bubble extends along and dilates the Schlemm'"'"'s canal at a location between the second aperture and the first aperture.

14. The method of claim 12, wherein the Schlemm'"'"'s canal is dilated with the gas bubble between the first aperture and the second aperture.

15. The method of claim 12, wherein the gas bubble from the second treatment site travels along the Schlemm'"'"'s canal to the first aperture.

16. The method of claim 12, wherein the photoablating of the ocular tissue at the second treatment site is performed in an enclosed volume of the eye and the gas bubble provides an increase in pressure within the enclosed volume.

17. The method of claim 12, wherein the Schlemm'"'"'s canal is dilated with the gas bubble and dilation of the Schlemm'"'"'s canal allows a larger volume of flow through the Schlemm'"'"'s canal, thereby increasing outflow.

18. The method of claim 12, wherein treatment comprises the photoablating ocular tissue at the first treatment site and the photoablating ocular tissue at the second treatment site and wherein an intraocular pressure of the eye is decreased by 20% or more after the treatment as compared to before the treatment.

19. The method of claim 12, wherein the gas bubble provides dilation of confluent connector channels in the eye.

20. The method of claim 12, comprising:

controlling the gas bubble generation by controlling process parameters applied during the photoablating of the ocular tissue at each of the first and second treatment sites, wherein the process parameters comprise a pulse duration, repetition rate, and/or photo density of a laser that is used for the photoablating of the ocular tissue at each of the first and second treatment sites.

21. The method of claim 12, wherein a number of apertures formed in the ocular tissue between the anterior chamber and the Schlemm'"'"'s canal is more than two, the number of apertures including the first aperture and the second aperture.